KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Return on Invested Capital (2020 - 2025)

Historic Return on Invested Capital for GoodRx Holdings (GDRX) over the last 6 years, with Q3 2025 value amounting to 0.04%.

  • GoodRx Holdings' Return on Invested Capital fell 400.0% to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.03% for FY2024, which is 300.0% up from last year.
  • Latest data reveals that GoodRx Holdings reported Return on Invested Capital of 0.04% as of Q3 2025, which was down 400.0% from 0.05% recorded in Q2 2025.
  • GoodRx Holdings' Return on Invested Capital's 5-year high stood at 0.08% during Q3 2024, with a 5-year trough of 0.4% in Q1 2021.
  • For the 5-year period, GoodRx Holdings' Return on Invested Capital averaged around 0.05%, with its median value being 0.0% (2024).
  • Over the last 5 years, GoodRx Holdings' Return on Invested Capital had its largest YoY gain of 4000bps in 2021, and its largest YoY loss of -2600bps in 2021.
  • Quarter analysis of 5 years shows GoodRx Holdings' Return on Invested Capital stood at 0.04% in 2021, then crashed by -94bps to 0.0% in 2022, then tumbled by -235bps to 0.0% in 2023, then surged by 1079bps to 0.03% in 2024, then skyrocketed by 55bps to 0.04% in 2025.
  • Its Return on Invested Capital stands at 0.04% for Q3 2025, versus 0.05% for Q2 2025 and 0.04% for Q1 2025.